Abstract is: Becker muscular dystrophy is an X-linked recessive inherited disorder characterized by slowly progressing muscle weakness of the legs and pelvis. It is a type of dystrophinopathy. This is caused by mutations in the dystrophin gene, which encodes the protein dystrophin. Becker muscular dystrophy is related to Duchenne muscular dystrophy in that both result from a mutation in the dystrophin gene, but has a milder course.
| rare disease | Q929833 |
| class of disease | Q112193867 |
| disease | Q12136 |
| muscular dystrophy | Q1137767 |
| Duchenne and Becker muscular dystrophy | Q55786602 |
| P699 | Disease Ontology ID | DOID:9883 |
| P557 | DiseasesDB | 1280 |
| P673 | eMedicine ID | 313417 |
| P1417 | Encyclopædia Britannica Online ID | science/Becker-muscular-dystrophy |
| P2888 | exact match | http://identifiers.org/doid/DOID:9883 |
| http://purl.obolibrary.org/obo/DOID_9883 | ||
| P646 | Freebase ID | /m/03_7zz |
| P4317 | GARD rare disease ID | 5900 |
| P494 | ICD-10 ID | G71.0 |
| P4229 | ICD-10-CM | G71.01 |
| P7807 | ICD-11 ID (Foundation) | 690532643 |
| P7329 | ICD-11 ID (MMS) | 8C70.0 |
| P493 | ICD-9 ID | 359.1 |
| P665 | KEGG ID | H01964 |
| P3201 | Medical Dictionary for Regulatory Activities ID | 10028356 |
| 10028356 | ||
| P604 | MedlinePlus ID | 000706 |
| 000706 | ||
| P6366 | Microsoft Academic ID | 2777775185 |
| P5270 | Mondo ID | MONDO_0010311 |
| P1748 | NCI Thesaurus ID | C84587 |
| P1245 | OmegaWiki Defined Meaning | 744728 |
| P492 | OMIM ID | 300376 |
| 300376 | ||
| P1550 | Orphanet ID | 98895 |
| P1461 | Patientplus ID | beckers-muscular-dystrophy |
| P4233 | PatientsLikeMe condition ID | becker-dystrophy |
| P5082 | Store medisinske leksikon ID | Beckers_muskeldystrofi |
| P2892 | UMLS CUI | C0699741 |
| P11430 | UniProt disease ID | DI-00178 |
| P11143 | WikiProjectMed ID | Becker muscular dystrophy |
| P3471 | WikiSkripta article ID | 69228 |
| P1889 | different from | Duchenne muscular dystrophy | Q1648484 |
| P2293 | genetic association | DMD | Q14864292 |
| P828 | has cause | mutation | Q42918 |
| P1995 | health specialty | neurology | Q83042 |
| P923 | medical examination | electromyography | Q507369 |
| muscle biopsy | Q2094702 | ||
| genetic testing | Q285223 | ||
| creatine kinase measurement | Q90834779 | ||
| P138 | named after | Peter Emil Becker | Q95892 |
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| P924 | possible treatment | antiarrhythmic agent | Q241549 |
| physiotherapy | Q186005 | ||
| gene therapy | Q213901 | ||
| occupational therapy | Q380141 | ||
| P1193 | prevalence | 0.0000261 | |
| P780 | symptoms and signs | cardiomyopathy | Q847583 |
| muscle weakness | Q270421 |
| Q54797549 | BMD-iPS1 |
| Q54797552 | BMD-iPS4 |
| Q54797554 | BMD2-iPS1 |
| Q54797556 | BMD2-iPS5 |
| Q54808984 | CCMi002-A |
| Q93445533 | CCMi004-A |
| Q127380796 | DMBi009-A |
| Q127380797 | DMBi009-A-1 |
| Q54831285 | DMD-iPS1 |
| Q54831287 | DMD-iPS2 |
| Q54835626 | GENEA058 |
| Q54837412 | GM02298 |
| Q54838571 | GM04569 |
| Q54838791 | GM04981 |
| Q54838844 | GM05081 |
| Q54838845 | GM05082 |
| Q54838848 | GM05089 |
| Q54838849 | GM05090 |
| Q54852906 | GM23127 |
| Q54852923 | GM23230 |
| Q54852945 | GM23262 |
| Q54890369 | HPS0232 |
| Q54890370 | HPS0233 |
| Q54890371 | HPS0234 |
| Q112929867 | INNDSUi003-A |
| Q105511782 | XMDYYYi001-A |
| Q101127244 | (-)-Epicatechin induces mitochondrial biogenesis and markers of muscle regeneration in adults with Becker muscular dystrophy |
| Q93096694 | A Case of Becker Muscular Dystrophy With Rimmed Vacuoles and Normal Dystrophin |
| Q51194592 | A Case of Refractory Heart Failure in Becker Muscular Dystrophy Improved With Corticosteroid Therapy. |
| Q50536354 | A Novel Mutation in DMD (c.10797+5G>A) Causes Becker Muscular Dystrophy Associated with Intellectual Disability. |
| Q89702468 | A Novel Mutation in N-Terminal Actin-Binding Domain of the DMD Gene Presenting Becker Muscular Dystrophy as Recurrent Exertional Rhabdomyolysis: A Case Report |
| Q102153445 | A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults |
| Q74460745 | A case of Becker muscular dystrophy and massive myoglobinuria with minimal renal manifestations |
| Q71667304 | A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation |
| Q36266919 | A case of Becker muscular dystrophy with early manifestation of cardiomyopathy |
| Q50306542 | A case of Becker muscular dystrophy with schizophrenic symptoms |
| Q36220734 | A case report: Becker muscular dystrophy presenting with epilepsy and dysgnosia induced by duplication mutation of Dystrophin gene |
| Q89485980 | A comparison of swallowing dysfunction in Becker muscular dystrophy and Duchenne muscular dystrophy |
| Q34459245 | A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East China |
| Q57405722 | A giant locus for the Duchenne and Becker muscular dystrophy gene |
| Q33594206 | A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers |
| Q72550863 | A molecular survey of Israeli Duchenne and Becker muscular dystrophy patients |
| Q88220370 | A novel dystrophin deletion mutation in a becker muscular dystrophy patient with early-onset dilated cardiomyopathy |
| Q90919311 | A novel mutation of dystrophin in a Becker muscular dystrophy family with severe cardiac involvement: from genetics to clinicopathology |
| Q35888853 | A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy |
| Q42662258 | A novel splice site mutation in a Becker muscular dystrophy patient |
| Q74109396 | A point mutation in the glycerol kinase gene associated with a deletion in the dystrophin gene in a familial X-linked muscular dystrophy: non-contiguous gene syndrome involving Becker muscular dystrophy and glycerol kinase loci |
| Q71339095 | A quantitative polymerase chain reaction (PCR) assay completely discriminates between Duchenne and Becker muscular dystrophy deletion carriers and normal females |
| Q67711128 | A rare case of adult-onset Becker muscular dystrophy diagnosed by dystrophin staining |
| Q41010730 | A rare subclinical or mild type of Becker muscular dystrophy caused by a single exon 48 deletion of the dystrophin gene |
| Q34047433 | A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales |
| Q50555274 | Abnormal short-latency synaptic plasticity in the motor cortex of subjects with Becker muscular dystrophy: a rTMS study. |
| Q43673098 | Abnormality of the myocardial sympathetic nervous system in a patient with Becker muscular dystrophy detected with iodine-123 metaiodobenzylguanidine scintigraphy |
| Q69366976 | Absence of dystrophin in Becker muscular dystrophy |
| Q45109398 | Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions |
| Q67995453 | Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions |
| Q67995457 | Additional dystrophin fragment in Becker muscular dystrophy patients: correlation with the pattern of DNA deletion |
| Q99213454 | Advances in Genetic Characterization and Genotype-Phenotype Correlation of Duchenne and Becker Muscular Dystrophy in the Personalized Medicine Era |
| Q31056857 | Age at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet |
| Q73192552 | Allele frequencies of intragenic, and 5' and 3' markers of the dystrophin gene in Japanese families afflicted with Duchenne or Becker muscular dystrophy |
| Q64220648 | An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy |
| Q68521087 | An unusual variant of Becker muscular dystrophy |
| Q33597671 | Analysis of Scottish Duchenne and Becker muscular dystrophy families with dystrophin cDNA probes |
| Q33680612 | Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy |
| Q38126937 | Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures |
| Q67988117 | Application of DNA probes to carrier detection and prenatal diagnosis of Duchenne (and Becker) muscular dystrophy |
| Q92361405 | Assessing the barriers to cardiac care in carriers of Duchenne and Becker muscular dystrophy |
| Q45881437 | Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion |
| Q72883571 | Asymptomatic Becker muscular dystrophy: expression of dystrophin and dystrophin-related protein |
| Q72646339 | Asymptomatic Becker muscular dystrophy: histological changes in biopsied muscles |
| Q73414464 | Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy |
| Q64046215 | Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders |
| Q33598438 | Becker muscular dystrophy (BMD) and Klinefelter's syndrome: a possible cause of variable expression of BMD within a pedigree |
| Q73325533 | Becker muscular dystrophy associated with focal myositis on bone scintigraphy |
| Q90981574 | Becker muscular dystrophy associated with sarcomeric hypertrophic cardiomyopathy in a paediatric patient: a case report |
| Q46115712 | Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene |
| Q91387543 | Becker muscular dystrophy caused by exon 2-truncating mutation of DMD |
| Q57908898 | Becker muscular dystrophy combined with x-linked Charcot-Marie-Tooth neuropathy |
| Q50488606 | Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript. |
| Q36116280 | Becker muscular dystrophy due to an inversion of exons 23 and 24 of the DMD gene |
| Q79763352 | Becker muscular dystrophy in Indian patients: analysis of dystrophin gene deletion patterns |
| Q44715462 | Becker muscular dystrophy in a patient with Hodgkin's disease |
| Q67895744 | Becker muscular dystrophy or spinal muscular atrophy?—Dystrophin studies resolve conflicting results of electromyography and muscle biopsy |
| Q33597923 | Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy |
| Q82889794 | Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients |
| Q73165583 | Becker muscular dystrophy presenting as eosinophilic inflammatory myopathy in an infant |
| Q71749013 | Becker muscular dystrophy presenting with complete heart block in the sixth decade |
| Q58519704 | Becker muscular dystrophy recombinant DNA studies in identical twins |
| Q63192023 | Becker muscular dystrophy severity is linked to the structure of dystrophin |
| Q74756886 | Becker muscular dystrophy with bundle branch reentry ventricular tachycardia |
| Q70483328 | Becker muscular dystrophy with early manifestation of left heart failure |
| Q83192079 | Becker muscular dystrophy with marked divergence between clinical and molecular genetic findings: case series |
| Q52512852 | Becker muscular dystrophy with onset after 60 years. |
| Q51692758 | Becker muscular dystrophy with r(X) carrying an out-of-frame DMD deletion. |
| Q60772362 | Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2 |
| Q45904823 | Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2. |
| Q33624277 | Becker muscular dystrophy: an unusual presentation |
| Q72043855 | Becker muscular dystrophy: an unusual presentation |
| Q69913980 | Becker muscular dystrophy: carrier detection by real-time ultrasound |
| Q41670916 | Becker muscular dystrophy: correlation of deletion type with clinical severity |
| Q68045274 | Becker muscular dystrophy: demonstration of the carrier status of a female by immunoblotting and immunostaining |
| Q68075881 | Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis |
| Q84423459 | Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy |
| Q82871681 | Body composition and resting energy expenditure of individuals with Duchenne and Becker muscular dystrophy |
| Q47422028 | Calf muscle involvement in Becker muscular dystrophy: when size does not matter |
| Q84434236 | Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy |
| Q71517866 | Cardiac dysfunction with Becker muscular dystrophy |
| Q72654905 | Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy |
| Q71719167 | Cardiac function, metabolism and perfusion in Duchenne and Becker muscular dystrophy |
| Q37098320 | Cardiac involvement in Becker muscular dystrophy |
| Q46455088 | Cardiac involvement in Becker muscular dystrophy: role of cardiovascular magnetic resonance |
| Q26801616 | Cardiac involvement in Duchenne and Becker muscular dystrophy |
| Q70948722 | Cardiac involvement in a family with Becker muscular dystrophy |
| Q78005705 | Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy |
| Q51012454 | Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study. |
| Q77124046 | Cardiac involvement in myotonic dystrophy, Becker muscular dystrophy and mitochondrial myopathy: a five-year follow-up |
| Q36979169 | Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach |
| Q81943384 | Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy |
| Q79675577 | Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder |
| Q95545314 | Cardiac resynchronization therapy in becker muscular dystrophy |
| Q84586312 | Cardiac resynchronization therapy in becker muscular dystrophy: for which patients? |
| Q26746151 | Cardiomyopathy in becker muscular dystrophy: Overview |
| Q71581962 | Cardiorespiratory function in Duchenne and Becker muscular dystrophy |
| Q74043924 | Cardiovascular autonomic control in Becker muscular dystrophy |
| Q84568467 | Cardiovascular magnetic resonance imaging evaluation of two families with Becker muscular dystrophy |
| Q90079616 | Cardiovascular progenitor cells and tissue plasticity are reduced in a myocardium affected by Becker muscular dystrophy |
| Q57304763 | Carrier detection and microsatellite analysis of duchenne and becker muscular dystrophy in spanish families |
| Q35197057 | Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms |
| Q52672938 | Carrier detection in Becker muscular dystrophy using creatine kinase estimation and DNA analysis. |
| Q77813260 | Carrier detection in Duchenne and Becker muscular dystrophy Argentine families |
| Q71229488 | Carrier detection in Duchenne and Becker muscular dystrophy using dinucleotide repeat polymorphisms. A study in Mexican families |
| Q71186736 | Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT) |
| Q67485400 | Carrier detection of duchenne and becker muscular dystrophy using muscle dystrophin immunohistochemistry |
| Q37312201 | Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry |
| Q36803129 | Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy). |
| Q55475347 | Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation. |
| Q70817002 | Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin |
| Q50999350 | Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy. |
| Q73101996 | Clinical characteristics of aged Becker muscular dystrophy patients with onset after 30 years |
| Q50117240 | Clinical features of patients with Becker muscular dystrophy and deletions of the rod domain of dystrophin gene |
| Q104788090 | Coexistence of Becker muscular dystrophy and HLA-B27 positive spondyloarthritis |
| Q74545362 | Comparative analysis of PCR-deletion detection and immunohistochemistry in Brazilian Duchenne and Becker muscular dystrophy patients |
| Q92996733 | Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients |
| Q39044467 | Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy |
| Q90779664 | Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging |
| Q51979468 | Confirmation of Angelman syndrome in a boy previously reported as having Becker muscular dystrophy and severe mental retardation. |
| Q52673776 | Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I. |
| Q31922777 | Correlation between electroretinographic findings, clinical phenotypic and genotypic analysis in Duchenne and Becker muscular dystrophy |
| Q34518069 | Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies |
| Q30927375 | Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy |
| Q30896864 | Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability |
| Q33594985 | Cosegregation of schizophrenia with Becker muscular dystrophy: susceptibility locus for schizophrenia at Xp21 or an effect of the dystrophin gene in the brain? |
| Q64041140 | Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity |
| Q91589136 | Current and emerging therapies in Becker muscular dystrophy (BMD) |
| Q57200516 | DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients |
| Q68327865 | DNA analysis of Duchenne and Becker muscular dystrophy using pERT87 genomic probes and dystrophin cDNA probes--establishing the optimum strategy for carrier diagnosis in the Japanese population |
| Q69879418 | DNA deletion in boy with Becker muscular dystrophy |
| Q70170466 | DNA deletions in mild and severe Becker muscular dystrophy |
| Q69366975 | DNA probes in differential diagnosis of Becker muscular dystrophy and spinal muscular atrophy |
| Q99410973 | Decision-Making And Selection Bias in Four Observational Studies on Duchenne and Becker Muscular Dystrophy |
| Q70096800 | Definitive localization of Becker muscular dystrophy in Xp by linkage to a cluster of DNA polymorphisms (DXS43 and DXS9) |
| Q63681882 | Deletion analysis for Duchenne (and Becker) muscular dystrophy |
| Q79191390 | Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis |
| Q41855877 | Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype. |
| Q74778583 | Deletion patterns in Argentine patients with Duchenne and Becker muscular dystrophy |
| Q54063294 | Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec |
| Q30404905 | Deletions of fetal and adult muscle cDNA in Duchenne and Becker muscular dystrophy patients |
| Q68028978 | Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis |
| Q91771491 | Developmental delay and neuropsychiatric comorbidities associated with Duchenne and Becker muscular dystrophy |
| Q87164974 | Diagnosis of becker muscular dystrophy: Results of Re-analysis of DNA samples |
| Q57484624 | Diagnostic Accuracy of Phenotype Classification in Duchenne and Becker Muscular Dystrophy Using Medical Record Data1 |
| Q87581041 | Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy |
| Q67987762 | Diagnostic criteria for Duchenne and Becker muscular dystrophy |
| Q67895424 | Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy |
| Q59402351 | Differences in cardiac involvement between carriers of Duchenne and Becker muscular dystrophy - a cardiovascular magnetic resonance study |
| Q37675985 | Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients |
| Q68626605 | Differentiation of Becker muscular dystrophy from limb-girdle muscular dystrophy and Kugelberg-Welander disease using a cDNA probe |
| Q40560855 | Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin |
| Q68163377 | Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA |
| Q67680758 | Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA |
| Q32121496 | Disorganization of dystrophin costameric lattice in Becker muscular dystrophy |
| Q37591778 | Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large Cohort |
| Q96027033 | Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing |
| Q41579811 | Duchenne and Becker muscular dystrophy complicated with epilepsy |
| Q67875878 | Duchenne and Becker muscular dystrophy in Chile |
| Q54918633 | Duchenne and Becker muscular dystrophy in adolescents: current perspectives. |
| Q34727386 | Duchenne and Becker muscular dystrophy mutations: analysis using 2.6 kb of muscle cDNA from the 5' end of the gene. |
| Q85040394 | Duchenne and Becker muscular dystrophy presenting as nonalcoholic fatty liver disease |
| Q72417842 | Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected |
| Q51757419 | Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach. |
| Q37196723 | Duchenne and Becker muscular dystrophy: contribution of a molecular and immunohistochemical analysis in diagnosis in Morocco |
| Q34725121 | Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy |
| Q83205342 | Duchenne or Becker muscular dystrophy: a clinical, genetic and immunohistochemical study in China |
| Q51669534 | Dystrophin Hot-Spot Mutants Leading to Becker Muscular Dystrophy Insert More Deeply into Membrane Models than the Native Protein. |
| Q82098057 | Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy |
| Q60178243 | Dystrophin analysis in duchenne and becker muscular dystrophy carriers: Correlation with intracellular calcium and albumin |
| Q33590398 | Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy |
| Q35195789 | Dystrophin in frameshift deletion patients with Becker muscular dystrophy |
| Q54508616 | Dystrophin levels and clinical severity in Becker muscular dystrophy patients. |
| Q35606737 | Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials |
| Q72895754 | Dystrophin-positive myotubes in innervated muscle cultures from Duchenne and Becker muscular dystrophy patients |
| Q72699791 | Dystrophin-related protein in Becker muscular dystrophy |
| Q99578655 | Early Detection of Subclinical Cardiac Involvement with Novel Cardiac Imaging Modalities in a Patient with Becker Muscular Dystrophy |
| Q74110036 | Early cardiac failure in a child with Becker muscular dystrophy is due to an abnormally low amount of dystrophin transcript lacking exon 13 |
| Q67485398 | Early differentiation between Duchenne and Becker muscular dystrophy: clinical, laboratory, electrophysiology, histochemical, and immunohistochemical study of 138 cases |
| Q35220292 | Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27 |
| Q65369586 | Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients |
| Q60772304 | Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy |
| Q69909432 | Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy |
| Q72586241 | Effects of electrical stimulation on muscles of children with Duchenne and Becker muscular dystrophy |
| Q90019261 | Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications |
| Q82215319 | Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy |
| Q88873886 | Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy |
| Q91028234 | Evaluation of Left-Sided Heart Chambers With Novel Echocardiographic Techniques in Men With Duchenne or Becker Muscular Dystrophy |
| Q84343498 | Evaluation of muscle oxygenation by near-infrared spectroscopy in patients with Becker muscular dystrophy |
| Q51677375 | Evaluation of point mutations in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients: introducing three novel variants. |
| Q58052228 | Evaluation of the cardiomyopathy in becker muscular dystrophy |
| Q73949073 | Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period |
| Q92529148 | Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy |
| Q43270441 | Exonization of an Intronic LINE-1 Element Causing Becker Muscular Dystrophy as a Novel Mutational Mechanism in Dystrophin Gene |
| Q67988118 | Experience with DNA analysis in Duchenne and Becker muscular dystrophy families in NSW |
| Q89425385 | Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence |
| Q35196969 | Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies |
| Q42117182 | Extensive Functional Evaluations to Monitor Aerobic Training in Becker Muscular Dystrophy: A Case Report |
| Q71041700 | Extraocular muscle involvement in Becker muscular dystrophy |
| Q92704841 | First familial Becker muscular dystrophy in Tanzania: Clinical and genetic features |
| Q92685372 | First psychotic episode in an adult with Becker muscular dystrophy |
| Q50304466 | Four siblings with becker muscular dystrophy (BMD) manifesting severe mental retardation |
| Q38991323 | Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families. |
| Q40991213 | Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies |
| Q72580578 | Gastrocnemius fasciotomy in Becker muscular dystrophy |
| Q74605066 | Gene deletion and carrier detection in the family of Becker muscular dystrophy by short tandem repeat sequence polymorphism |
| Q50135369 | Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55). |
| Q94458929 | Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C |
| Q68085636 | Genetic counselling in Duchenne and Becker muscular dystrophy is problematic when carrier studies give controversial results |
| Q46245078 | Genetic diagnosis of Duchenne and Becker muscular dystrophy using multiplex ligation-dependent probe amplification in Rwandan patients |
| Q85037668 | Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform |
| Q73250693 | Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia |
| Q33670706 | Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome |
| Q70180244 | Genetic linkage relationship between the Xg blood group system and two X chromosome DNA polymorphisms in families with Duchenne and Becker muscular dystrophy |
| Q70096806 | Genetic linkage relationships of seven DNA probes with Duchenne and Becker muscular dystrophy |
| Q70161385 | Genetic linkage study between the loci for Duchenne and Becker muscular dystrophy and nine X-chromosomal DNA markers |
| Q73066834 | Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients |
| Q102386076 | Genotype-Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry |
| Q89435449 | Genotype-phenotype correlation in Becker muscular dystrophy in Chinese patients |
| Q66038889 | Gentamicin Treatment of Muscular Dystrophy |
| Q43642581 | Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations |
| Q41860729 | Growth hormone deficiency in a patient with becker muscular dystrophy: a pediatric case report. |
| Q57168338 | Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences S |
| Q33923247 | Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy |
| Q78048699 | High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for genetic counseling |
| Q58036261 | Homozygous female Becker muscular dystrophy |
| Q91796362 | How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event |
| Q64069475 | Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies |
| Q88019225 | Identification of sleep hypoventilation in young individuals with Becker muscular dystrophy: A pilot study |
| Q60910524 | Impaired Glucose Tolerance in Adults with Duchenne and Becker Muscular Dystrophy |
| Q69527738 | Improved diagnosis of Becker muscular dystrophy by dystrophin testing |
| Q72342998 | In utero fetal muscle biopsy alters diagnosis and carrier risks in Duchenne and Becker muscular dystrophy |
| Q92724276 | Instruments for the Assessment of Behavioral and Psychosocial Functioning in Duchenne and Becker Muscular Dystrophy; a Systematic Review of the Literature |
| Q59248813 | Integrated Backscatter in Becker Muscular Dystrophy Patients With Functionally Normal Heart: Myocardial Ultrasound Tissue Characterization Study |
| Q46388457 | Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule |
| Q72795527 | Interrelationship between gene, its product and phenotype in Duchenne and Becker muscular dystrophy |
| Q57456679 | Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy |
| Q91375555 | Intramuscular blood flow in Duchenne and Becker Muscular Dystrophy: Quantitative power Doppler sonography relates to disease severity |
| Q33594351 | Investigation of a female manifesting Becker muscular dystrophy |
| Q71748973 | Is dystrophin always altered in Becker muscular dystrophy patients? |
| Q70708753 | Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype? |
| Q69640512 | Is there a maturation defect related to calcium in muscle mitochondria from dystrophic mice and Duchenne and Becker muscular dystrophy patients |
| Q46481564 | LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype. |
| Q92085676 | Laparoscopic gynecological surgery in an adult woman with Becker muscular dystrophy performed with sevoflurane with cisatracurium anesthesia: A case report |
| Q35582781 | Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy |
| Q38548042 | Late-onset Becker muscular dystrophy: Refining the clinical features and electrophysiological findings. |
| Q51356574 | Left ventricular synchronization by biventricular pacing in Becker muscular dystrophy as assessed by tissue Doppler imaging. |
| Q70024957 | Letter: Serum-creatine-kinase levels in carriers of Becker muscular dystrophy |
| Q51733125 | Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. |
| Q51568549 | Life-threatening Arrhythmias in a Becker Muscular Dystrophy Family due to the Duplication of Exons 3-4 of the Dystrophin Gene. |
| Q33671990 | Linkage analysis of a DNA polymorphism proximal to the Duchenne and Becker muscular dystrophy loci on the short arm of the X chromosome |
| Q72567340 | Localisation of gene for Becker muscular dystrophy |
| Q41438546 | Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences |
| Q68086737 | Long-term electrical stimulation of muscles in children with Duchenne and Becker muscular dystrophy |
| Q94561306 | Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy |
| Q71952881 | Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy |
| Q87499601 | Magnetic resonance imaging phenotyping of Becker muscular dystrophy |
| Q51615764 | Malignant hyperthermia in a patient with Becker muscular dystrophy: dystrophin analysis and caffeine contracture study. |
| Q73374621 | Malignant hyperthermia-like episode in Becker muscular dystrophy |
| Q46714107 | Malignant hyperthermia-like reactions in Duchenne or Becker muscular dystrophy: review and hypothesis |
| Q73133202 | Manifestations of Duchenne and Becker muscular dystrophy among carriers |
| Q69732973 | Manifesting carrier of Becker muscular dystrophy (BMD): clinical and recombinant DNA studies |
| Q35200253 | Mapping of X-linked Becker muscular dystrophy through crossovers identified by DNA polymorphisms and by haplotype characterization in somatic cell hybrids |
| Q99605073 | MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy |
| Q40539157 | Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin |
| Q55318559 | Molecular Analysis-Based Genetic Characterization of a Cohort of Patients with Duchenne and Becker Muscular Dystrophy in Eastern China. |
| Q70513160 | Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy |
| Q79399711 | Molecular deletion patterns in Duchenne and Becker muscular dystrophy patients from KwaZulu Natal |
| Q49090730 | Molecular deletion patterns in Turkish Duchenne and Becker muscular dystrophy patients. |
| Q38657591 | Molecular genetics of Duchenne and Becker muscular dystrophy: emphasis on improved diagnosis |
| Q52477329 | Molecular pathology of Duchenne and Becker muscular dystrophy |
| Q70969778 | More deletions in the 5' region than in the central region of the dystrophin gene were identified among Filipino Duchenne and Becker muscular dystrophy patients |
| Q98207460 | Multi-parametric MR in Becker muscular dystrophy patients |
| Q64939062 | Multiple episodes of thrombosis in a patient with Becker muscular dystrophy with marked expression of utrophin on the muscle cell membrane. |
| Q72364158 | Multiplicity of abnormal dystrophin in Becker muscular dystrophy. A Becker muscular dystrophy gene frequently produced two smaller sizes of dystrophin |
| Q71933964 | Muscle CT scans in preclinical cases of Duchenne and Becker muscular dystrophy |
| Q84975033 | Muscle MRI in Becker muscular dystrophy |
| Q85265955 | Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy |
| Q66402443 | Muscle Oxygenation in Effort in Neuromuscular Diseases |
| Q67767408 | Muscle histology in becker muscular dystrophy |
| Q87295605 | Muscular dystrophy in a dog resembling human becker muscular dystrophy |
| Q43930231 | Mutation analysis in Duchenne and Becker muscular dystrophy patients from Bulgaria shows a peculiar distribution of breakpoints by intron |
| Q38383780 | Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial |
| Q59402350 | Myocardial characterisation in Becker muscular dystrophy using T1 and T2 mapping |
| Q45874833 | Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy. |
| Q64072473 | Needs management in families affected by childhood-onset dystrophinopathies |
| Q90935516 | Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy |
| Q43839087 | Non-Hodgkin's lymphoma of the ascending colon in a patient with becker muscular dystrophy: report of a case |
| Q34221402 | Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene |
| Q71146884 | Nonsense mutations in a Becker muscular dystrophy and an intermediate patient |
| Q77916383 | Normalization of creatine kinase level during arthritis in a patient with Becker muscular dystrophy |
| Q80146127 | Novel SHOX gene mutation in a short boy with Becker muscular dystrophy: double trouble in two adjacent genes |
| Q46069812 | Obesity and Premature Loss of Mobility in Two Adolescents with Becker Muscular Dystrophy After HeartMate II Implantation. |
| Q91505706 | Orofacial muscles may be affected in early stages of Becker muscular dystrophy: A preliminary study |
| Q57261198 | P01 Correlation of internally deleted dystrophin and dystrophin-associated protein expression with clinical severity in Becker muscular dystrophy |
| Q72816137 | PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy |
| Q81604652 | Pain and activity limitations in children with Duchenne or Becker muscular dystrophy |
| Q64115587 | Palliative care services in families of males with muscular dystrophy: Data from MD STARnet |
| Q57721540 | Parental perspectives on the diagnostic process for Duchenne and Becker muscular dystrophy |
| Q98784539 | Pathological evaluation of rats carrying in-frame mutations in the dystrophin gene: A new model of Becker muscular dystrophy |
| Q88582881 | Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup |
| Q44870922 | Patterns of deletions and the distribution of breakpoints in the dystrophin gene in Czech patients with Duchenne and Becker muscular dystrophy (statistical comparison with results from several other countries). |
| Q67930052 | Patterns of exon deletions in Duchenne and Becker muscular dystrophy |
| Q73668924 | Perturbation in dystrophin-associated glycoprotein complex in a boy with Becker muscular dystrophy |
| Q48262786 | Peter Becker and his Nazi past: the man behind Becker muscular dystrophy and Becker myotonia |
| Q64680670 | Phase 2b Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) |
| Q64725042 | Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD) |
| Q65369575 | Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy |
| Q83288667 | Physical training in Becker muscular dystrophy associated with heart failure |
| Q77114433 | Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy |
| Q70651013 | Plasma pyruvate kinase and creatine kinase activity in Becker muscular dystrophy |
| Q48142520 | Point mutation in a Becker muscular dystrophy patient |
| Q33592679 | Possibilities and limitation of prenatal diagnosis and carrier determination for Duchenne and Becker muscular dystrophy using cDNA probes |
| Q67951343 | Potential pitfalls in using DNA probes to counsel Duchenne and Becker muscular dystrophy families |
| Q69897598 | Prenatal diagnosis in Becker muscular dystrophy |
| Q82275908 | Prenatal molecular diagnosis of Duchenne and Becker muscular dystrophy |
| Q53875860 | Prevalence and Characteristics of Chinese Patients With Duchenne and Becker Muscular Dystrophy: A Territory Wide Collaborative Study in Hong Kong. |
| Q37425767 | Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto Rico |
| Q68296487 | Prevalence and incidence of Becker muscular dystrophy |
| Q24235432 | Prevention and treatment for cardiac complications in Duchenne and Becker muscular dystrophy |
| Q24201115 | Prevention and treatment for cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy |
| Q55483982 | Progression of myocardial fibrosis by magnetic resonance imaging in patients with Duchenne and Becker muscular dystrophy and preserved left ventricular ejection fraction - a randomized clinical trial for treatment with ACE inhibitors. |
| Q90625965 | Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study |
| Q73107340 | Proportion and pattern of dystrophin gene deletions in north Indian Duchenne and Becker muscular dystrophy patients |
| Q91625769 | Protein Interaction Mapping related to Becker Muscular Dystrophy |
| Q60297026 | Proximal Dystrophin Gene Deletions and Protein Alterations in Becker Muscular Dystrophy |
| Q35907748 | Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient |
| Q91215578 | Psychiatric and neurodevelopmental aspects of Becker muscular dystrophy |
| Q35206606 | Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study |
| Q35083512 | Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel |
| Q92891615 | Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy |
| Q33594787 | Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications |
| Q55688889 | Quantitative left ventricular rotational mechanics in Duchenne and Becker muscular dystrophy patients. |
| Q30472653 | Quantitative ultrasound using backscatter analysis in Duchenne and Becker muscular dystrophy |
| Q64695251 | Ramipril Versus Carvedilol in Duchenne and Becker Patients |
| Q92226522 | Rapidly Progressive Heart Failure in a Female Carrier of Becker Muscular Dystrophy with No Skeletal Muscle Symptoms |
| Q48666432 | Rare combination of Becker muscular dystrophy and Klinefelter's syndrome in one patient |
| Q79339612 | Re-evaluation of reading frame-shift hypothesis in Duchenne and Becker muscular dystrophy |
| Q36907558 | Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124). |
| Q72369821 | Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients |
| Q64931589 | Reply to "The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations". |
| Q70483948 | Report on the 16th ENMC workshop--carrier diagnosis of Duchenne and Becker muscular dystrophy |
| Q33596781 | Reproductive fitness and frequency of new mutations in Becker muscular dystrophy: implications for genetic risk estimates |
| Q97529290 | Respiratory Dysfunction in Becker Muscular Dystrophy Patients: A Case Series and Autopsy Report |
| Q84596670 | Respiratory surveillance of patients with Duchenne and Becker muscular dystrophy |
| Q85200695 | Response to: Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity |
| Q34517484 | Rimmed vacuoles in Becker muscular dystrophy have similar features with inclusion myopathies |
| Q43146517 | Screening Duchenne and Becker muscular dystrophy patients for deletions in 30 exons of the dystrophin gene by three-multiplex PCR |
| Q67552880 | Screening of glycerol kinase deficiency in patients affected by Duchenne and Becker muscular dystrophy |
| Q70101098 | Segregation analysis of a marker localised Xp21.2-Xp21.3 in Duchenne and Becker muscular dystrophy families |
| Q36367189 | Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy |
| Q33646732 | Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study |
| Q96171891 | Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G>A DMD splice-site mutation: a case report |
| Q77924716 | Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study |
| Q73257345 | Sleep apnea in a patient with Becker muscular dystrophy |
| Q102134449 | Slow oscillation density and amplitude decrease across development in pediatric Duchenne and Becker Muscular Dystrophy |
| Q47202784 | Social involvement issues in patients with Becker muscular dystrophy: A questionnaire survey of subjects from a patient registry |
| Q68059636 | Somatic mosaicism for a deletion of the dystrophin gene in a carrier of Becker muscular dystrophy |
| Q77972411 | Statistically significant differences in the number of CD24 positive muscle fibers and satellite cells between sarcoglycanopathy and age-matched Becker muscular dystrophy patients |
| Q72078643 | Steroid-responsive myalgia in a patient with Becker muscular dystrophy |
| Q64660201 | Study of Ataluren (PTC124®) in Nonambulatory Patients With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD) |
| Q64645369 | Study of Ataluren for Previously Treated Patients With nmDBMD in Europe, Israel, Australia, and Canada |
| Q87148472 | Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity |
| Q41509667 | Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity. |
| Q57261203 | T.P.31 Biochemical and clinical variability of Becker muscular dystrophy: Predicting optimal target exons for exon skipping therapy in Duchenne muscular dystrophy |
| Q47150895 | T1 mapping in Becker muscular dystrophy patients detects diffuse microfibrosis prior to evidence of late gadolinium enhancement or cardiac dysfunction. |
| Q36590389 | TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy |
| Q50858360 | The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study. |
| Q64986063 | The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations. |
| Q100492969 | The Neurocognitive and Behavioral Profiles of 3 Brothers With Becker Muscular Dystrophy |
| Q40984650 | The PJ Nicholoff Steroid Protocol for Duchenne and Becker Muscular Dystrophy and Adrenal Suppression |
| Q73865225 | The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related |
| Q33679539 | The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol |
| Q68122875 | The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy |
| Q35197608 | The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion |
| Q69501658 | The molecular principles of Duchenne and Becker muscular dystrophy and their genetic diagnosis |
| Q27622446 | The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy |
| Q56764399 | The ultrasound-guided nerve blocks of abdominal wall contributed to anesthetic management of cholecystectomy in a patient with Becker muscular dystrophy without using muscle relaxants |
| Q104284874 | Thyroid storm after mitral valve repair in a patient with Becker muscular dystrophy |
| Q57831005 | Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies |
| Q53627504 | Transplantation of human umbilical cord-derived mesenchymal stems cells for the treatment of Becker muscular dystrophy in affected pedigree members. |
| Q73813101 | Troponin T and troponin I in carriers of Duchenne and Becker muscular dystrophy with cardiac involvement |
| Q72809810 | Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation |
| Q92168439 | Update in Duchenne and Becker muscular dystrophy |
| Q95943223 | Urinary incontinence in men with Duchenne and Becker muscular dystrophy |
| Q66342355 | Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) |
| Q47817707 | Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy |
| Q36380419 | Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? |
| Q34335239 | Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy. |
| Q72714962 | Verification of carrier status for Becker muscular dystrophy from analysis of a blighted ovum |
| Q95293049 | What are the effects of treatments used to prevent or treat heart complications in Duchenne muscular dystrophy, Becker muscular dystrophy, and X-linked dilated cardiomyopathy? A Cochrane Review summary with commentary |
| Q67243653 | Wolff-Parkinson-White syndrome as initial manifestation of Becker muscular dystrophy |
| Q46494476 | Worsening of heart failure in Becker muscular dystrophy after nonsteroidal anti-inflammatory drugs |
| Q68732234 | X;autosome translocations in females with Duchenne or Becker muscular dystrophy |
| Q93121601 | Young Becker Muscular Dystrophy Patients Demonstrate Fibrosis Associated With Abnormal Left Ventricular Ejection Fraction on Cardiac Magnetic Resonance Imaging |
| Q68516100 | [A case of Becker muscular dystrophy presenting cardiac failure as an initial symptom] |
| Q72285283 | [A case of Down syndrome complicated with Becker muscular dystrophy] |
| Q92315314 | [A case of dilated cardiomyopathy caused by Becker muscular dystrophy] |
| Q72584759 | [A case of severe Becker muscular dystrophy diagnosed in early childhood--correlation between clinical severity and dystrophin testing] |
| Q73845769 | [A patient presented with atypical paroxysmal kinesigenic choreoathetosis and Becker muscular dystrophy] |
| Q53763560 | [Analysis of 18 cases of Becker muscular dystrophy] |
| Q84810163 | [Anesthetic management of a patient with Becker muscular dystrophy] |
| Q72221368 | [Application of RFLP analysis to Duchenne and Becker muscular dystrophy in Shandong Province. I. Carrier detections in females at risk] |
| Q78636174 | [Arrhythmias and heart rate variability in Duchenne and Becker muscular dystrophy] |
| Q71581144 | [Becker muscular dystrophy: clinical analysis, genetic and pathologic correlations] |
| Q68640984 | [Cardiomyopathy in Becker muscular dystrophy] |
| Q72234907 | [Carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy by PCR methods] |
| Q68549045 | [Carrier diagnosis and prenatal prognosis using DNA analysis in X-chromosome-linked Duchenne and Becker muscular dystrophy] |
| Q72460080 | [Clinical feature and mechanism of cardiac failure in patients with Becker muscular dystrophy] |
| Q74068572 | [Correlation of cardiac muscle involvement and the dystrophin gene abnormality in Becker muscular dystrophy] |
| Q72624479 | [Deletions within the gene of dystrophin in Duchenne and Becker muscular dystrophy] |
| Q77881311 | [Detection of carriers of Duchenne and Becker muscular dystrophy using the fluorescence in situ hybridization method] |
| Q74796280 | [Diagnosis of Duchenne and Becker muscular dystrophy in Slovak patients using multiplex polymerase chain reaction] |
| Q83912433 | [Diagnostic value of neuronal nitric oxide synthase antibody for clinically suspected Becker muscular dystrophy] |
| Q71790202 | [Dilated myocardiopathy in a patient with Becker muscular dystrophy] |
| Q77750972 | [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy] |
| Q90044892 | [Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy] |
| Q72179132 | [Genetic analysis of 60 Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) patients using dystrophin cDNA] |
| Q68046649 | [Importance of germ cell mosaic for genetic counseling of families with Duchenne and Becker muscular dystrophy] |
| Q67244880 | [Molecular pathology of Duchenne and Becker muscular dystrophy] |
| Q86231819 | [Mutation analysis and prenatal diagnosis of families affected with Duchenne and Becker muscular dystrophy] |
| Q68071255 | [New aspects of carrier diagnosis and human genetic counseling in Duchenne and Becker muscular dystrophy] |
| Q95790752 | [Prenatal diagnosis of Duchenne and Becker muscular dystrophy by multiplex ligation-dependent probe amplification] |
| Q80121489 | [Report of four women with Duchenne or Becker muscular dystrophy] |
| Q87092279 | [Specific features of Becker Muscular Dystrophy patients and female carriers of Duchenne Muscular Dystrophy] |
| Q84282003 | [Study of dystrophin gene non-deletion/duplication mutations causing Becker muscular dystrophy] |
| Q95610825 | [Successful anesthetic management of laparoscopic rectopexy using rocuronium and sugammadex in a patient with Becker muscular dystrophy] |
| Q83970466 | [The use of rocuronium in a patient with Becker muscular dystrophy] |
| Q79831987 | [Transient normalisation of CK in a patient with Becker muscular dystrophy and testicular germ cell tumor: an effect of chemotherapy?] |
| Q73506184 | [Use of CA repeat polymorphism in direct and indirect diagnosis of Duchenne and Becker muscular dystrophy] |
| Q105725280 | Pierre Lapin | medical condition | P1050 |
| Category:Becker muscular dystrophy | wikimedia | |
| Arabic (ar / Q13955) | سوء التغذية العضلي لبيكر | wikipedia |
| Beckerova mišićna distrofija | wikipedia | |
| Catalan (ca / Q7026) | Distrofia muscular de Becker | wikipedia |
| ckb | نەخۆشی دیسترۆفی ماسوولکەیی بێکەر | wikipedia |
| Beckerova svalová dystrofie | wikipedia | |
| Muskeldystrophie Becker-Kiener | wikipedia | |
| Μυϊκή δυστροφία Μπέκερ | wikipedia | |
| Becker muscular dystrophy | wikipedia | |
| Distrofia muscular de Becker | wikipedia | |
| Persian (fa / Q9168) | دیستروفی ماهیچهای بکر | wikipedia |
| Beckerin lihasdystrofia | wikipedia | |
| Dystrophie musculaire de Becker | wikipedia | |
| Distrofia muscolare di Becker | wikipedia | |
| ベッカー型筋ジストロフィー | wikipedia | |
| mk | Бекерова мускулна дистрофија | wikipedia |
| nb | Beckers muskeldystrofi | wikipedia |
| Spierdystrofie van Becker | wikipedia | |
| or | ବେକର ମାଂସପେଶୀ ଡିଷ୍ଟ୍ରୋଫି | wikipedia |
| pms | Distrofìa muscolar ëd Becker | wikipedia |
| Distrofia muscular de Becker | wikipedia | |
| Бекерова мишићна дистрофија | wikipedia | |
| Beckers muskeldystrofi | wikipedia | |
| М'язова дистрофія Беккера | wikipedia | |
| 貝克型肌肉萎縮症 | wikipedia |
Search more.